Histopathology

Comparative Biosciences, Inc. provides contract histology, immunohistochemistry, and pathology services to the biopharmaceutical industry.  Whether preparing a single biopsy or a complete carcinogenicity study, CBI offers high quality slide preparation, pathological evaluation, and report preparation in a timely and cost effective manner. 

Founded in 1996, CBI is a prestigious, independent, privately owned, nationally and internationally recognized histology and pathology laboratory serving the biopharmaceutical and life sciences industry.  We are committed to providing the highest quality histology and pathology services to our clients. 

Located in the heart of Silicon Valley, CBI features state-of-the-art laboratories, the most up to date equipment, and an expert staff drawn from the dynamic academic and biotechnology environment surrounding Silicon Valley, Stanford University, UCSF and Berkeley.

Our resources include highly trained and experienced board-certified veterinary pathologists, skilled and detail-oriented technical personnel and full-time quality assurance staff. We are committed to providing the highest level of quality in a cost effective and time efficient manner. All CBI studies are conducted within our laboratories, under the direct supervision of our pathologist, QAU and PhD level scientific managers.

For preparation of histology and pathology studies for regulatory submission, CBI follows FDA, OECD, EPA, STP, NTP, MHW, FISA and EMEA guidelines. Our Quality Assurance Unit audits all critical phases of GLP studies and all phases of slide preparation are overseen by a board certified veterinary pathologist assuring the highest quality slide preparation.

Our clients include pharmaceutical and biotechnology companies, universities, colleges of veterinary medicine, NIH/NIEHS/NPT and other federal grant funded organizations, hospitals, and basic researchers.

Follow the links for more detailed capabilities and services.